vaccines@mdpi.com To: Isam Bsisu isam_bsisu@hotmail.com Cc: Rami Alqassieh Rami_qaisieh@yahoo.com, Aiman Suleiman Asuleima@bidmc.harvard.edu, Sami Abu- Halaweh s.halaweh@ju.edu.jo, Abeer Santarisi abeer_santarisi@yahoo.com, Omar Shatnawi Omar.juve10@gmail.com, Lara Shdaifat Shdaifatlara@gmail.com, Amjed Tarifi amjed.tarifi@gmail.com, Mohammad Al-Tamimi mohammad.altamimi@hu.edu.jo, Abdel- Ellah Al-Shudifat amalmufleh@hotmail.com, Heba Alsmadi Sw006999@gmail.com, Ahmed Al Sharqawi sharqawiahmed@gmail.com, Hadeel Alnawaiseh Hanabrklna@gmail.com, Yara Anasweh Yara.anasweh@gmail.com, Farah Abo Domaidah farahabodomaidah@gmail.com, Haneen Abu Jaber abujaber.haneen@gmail.com, Mohammad Rashid Al-Zarir rashed.zaareer@gmail.com, Vaccines Editorial Office vaccines@mdpi.com, Ovidiu Radu ovidiu.radu@mdpi.com Sent: Monday, October 18, 2021, 11:12 AM
Dear Dr. Bsisu,
Congratulations on the acceptance of your
manuscript, and thank you for your interest in submitting your work to Vaccines: Manuscript ID: vaccines-1361698 Type of manuscript: Article Title: Pfizer-BioNTech and Sinopharm: a comparative study on post-vaccination antibody titers Authors: Rami Alqassieh, Aiman Suleiman, Sami Abu-Halaweh, Abeer Santarisi, Omar Shatnawi, Lara Shdaifat, Amjed Tarifi, Mohammad Al-Tamimi, Abdel-Ellah Al-Shudifat, Heba Alsmadi, Ahmed Al Sharqawi, Hadeel Alnawaiseh, Yara Anasweh, Farah Abo Domaidah, Haneen Abu Jaber, Mohammad Rashid Al-Zarir, Isam Bsisu * Received: 14 August 2021 E-mails: Rami_qaisieh@yahoo.com, Asuleima@bidmc.harvard.edu, s.halaweh@ju.edu.jo, abeer_santarisi@yahoo.com, Omar.juve10@gmail.com, Shdaifatlara@gmail.com, amjed.tarifi@gmail.com, mohammad.altamimi@hu.edu.jo, amalmufleh@hotmail.com, Sw006999@gmail.com, sharqawiahmed@gmail.com, Hanabrklna@gmail.com, Yara.anasweh@gmail.com, farahabodomaidah@gmail.com, abujaber.haneen@gmail.com, rashed.zaareer@gmail.com, isam_bsisu@hotmail.com Submitted to section: COVID-19 Vaccines and Vaccination, https://www.mdpi.com/journal/vaccines/sectio ns/COVID-19_vaccines_vaccination https://susy.mdpi.com/user/manuscripts/revie w_info/75c6b09ad14ae1c6d36f0672d9efebe6
We will now edit and finalize your paper, which
will then be returned to you for your approval. Within the next couple of days, an invoice concerning the article processing charge (APC) for publication in this open access journal will be sent by email from the Editorial Office in Basel, Switzerland.
If, however, extensive English edits are required
to your manuscript, we will need to return the paper requesting improvements throughout.
We encourage you to set up your profile at
SciProfiles.com, MDPI’s researcher network platform. Articles you publish with MDPI will be linked to your SciProfiles page, where colleagues and peers will be able to see all of your publications, citations, as well as other academic contributions.
We also invite you to contribute to Encyclopedia
(https://encyclopedia.pub), a scholarly platform providing accurate information about the latest research results. You can adapt parts of your paper to provide valuable reference information, via Encyclopedia, for others both within the field and beyond.